Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Westerink

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
European Heart Journal|September 11, 2019
The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort studyCilie C Van't Klooster, Paul M Ridker, Jesper Hjortnaes, et al.
Journal of Thrombosis and Haemostasis : JTH|May 24, 2022
Post-thrombotic syndrome after upper extremity deep vein thrombosis: An international Delphi consensus studyRobert J C M F de Kleijn, Ludo Schropp, Eline S van Hattum, et al.
European Journal of Clinical Investigation|May 17, 2022
Lifestyle changes and kidney function: A 10-year follow-up study in patients with manifest cardiovascular diseaseHelena Bleken Østergaard, Imre Demirhan, Jan Westerink, et al.
Acta Diabetologica|September 28, 2018
Thyroid-stimulating hormone levels in the normal range and incident type 2 diabetes mellitusT I de Vries, L J Kappelle, Y van der Graaf, et al.
International Journal of Cardiology|July 22, 2017
Decline in risk of recurrent cardiovascular events in the period 1996 to 2014 partly explained by better treatment of risk factors and less subclinical atherosclerosisGijs F N Berkelmans, Yolanda van der Graaf, Jannick A N Dorresteijn, et al.
JACC. Cardiooncology|August 16, 2021
Prediction of Lifetime and 10-Year Risk of Cancer in Individual Patients With Established Cardiovascular DiseaseCilie C van 't Klooster, Paul M Ridker, Nancy R Cook, et al.
Annals of Vascular Surgery|August 30, 2021
Variation in perioperative cerebral and hemodynamic monitoring during carotid endarterectomyLeonie Mm Fassaert, Raechel J Toorop, Bart-Jeroen Petri, et al.
Journal of Nephrology|March 13, 2021
End-stage kidney disease in patients with clinically manifest vascular disease; incidence and risk factors: results from the UCC-SMART cohort studyHelena Bleken Østergaard, Jan Westerink, Marianne C Verhaar, et al.
Research and Practice in Thrombosis and Haemostasis|March 6, 2023
The upper extremity postthrombotic syndrome score: an international Delphi consensus study to determine the score's functional disability componentLudo Schropp, Roos B Cats, Robert J C M F de Kleijn, et al.
Diabetes Research and Clinical Practice|October 20, 2019
Normal-range thyroid-stimulating hormone levels and cardiovascular events and mortality in type 2 diabetesTamar I de Vries, Harold W de Valk, Yolanda van der Graaf, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
European Heart Journal|September 11, 2019
The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort studyCilie C Van't Klooster, Paul M Ridker, Jesper Hjortnaes, et al.
Journal of Thrombosis and Haemostasis : JTH|May 24, 2022
Post-thrombotic syndrome after upper extremity deep vein thrombosis: An international Delphi consensus studyRobert J C M F de Kleijn, Ludo Schropp, Eline S van Hattum, et al.
European Journal of Clinical Investigation|May 17, 2022
Lifestyle changes and kidney function: A 10-year follow-up study in patients with manifest cardiovascular diseaseHelena Bleken Østergaard, Imre Demirhan, Jan Westerink, et al.
Acta Diabetologica|September 28, 2018
Thyroid-stimulating hormone levels in the normal range and incident type 2 diabetes mellitusT I de Vries, L J Kappelle, Y van der Graaf, et al.
International Journal of Cardiology|July 22, 2017
Decline in risk of recurrent cardiovascular events in the period 1996 to 2014 partly explained by better treatment of risk factors and less subclinical atherosclerosisGijs F N Berkelmans, Yolanda van der Graaf, Jannick A N Dorresteijn, et al.
JACC. Cardiooncology|August 16, 2021
Prediction of Lifetime and 10-Year Risk of Cancer in Individual Patients With Established Cardiovascular DiseaseCilie C van 't Klooster, Paul M Ridker, Nancy R Cook, et al.
Annals of Vascular Surgery|August 30, 2021
Variation in perioperative cerebral and hemodynamic monitoring during carotid endarterectomyLeonie Mm Fassaert, Raechel J Toorop, Bart-Jeroen Petri, et al.
Journal of Nephrology|March 13, 2021
End-stage kidney disease in patients with clinically manifest vascular disease; incidence and risk factors: results from the UCC-SMART cohort studyHelena Bleken Østergaard, Jan Westerink, Marianne C Verhaar, et al.
Research and Practice in Thrombosis and Haemostasis|March 6, 2023
The upper extremity postthrombotic syndrome score: an international Delphi consensus study to determine the score's functional disability componentLudo Schropp, Roos B Cats, Robert J C M F de Kleijn, et al.
Diabetes Research and Clinical Practice|October 20, 2019
Normal-range thyroid-stimulating hormone levels and cardiovascular events and mortality in type 2 diabetesTamar I de Vries, Harold W de Valk, Yolanda van der Graaf, et al.
Pageof 12